Addison's disease: why a hormone problem turns the skin bronze

A rescue signal that cannot be heard where it is aimed, overheard instead by the skin — the body writing its diagnosis in pigment.

Of all the places the melanocortin system surfaces, few are as clinically beautiful as this one. Addison’s disease — primary adrenal insufficiency — is a disorder of a missing hormone, cortisol. Yet its most famous sign is written on the skin: a deepening, bronze pigmentation. The connection between a failing adrenal gland and a darkening skin looks mysterious until you know the melanocortin system, at which point it becomes almost inevitable.^[2]

A rescue signal overheard by the skin

The adrenal glands sit under the control of the pituitary, which drives them with ACTH. Normally cortisol feeds back to the pituitary and tells it when to ease off — a thermostat. In Addison’s disease the adrenal cortex is damaged and cannot make cortisol, so that feedback signal never arrives. The pituitary, sensing no cortisol, does the only thing it can: it pushes harder, manufacturing ever more POMC and releasing ever more ACTH in a bid to flog a gland that cannot respond.^[1]

Here is the twist that makes it a pigment disease. ACTH is cut from POMC, and its first thirteen amino acids are identical to α-MSH, the melanocortin that drives pigmentation. ACTH is, in effect, α-MSH with a tail. So when the pituitary floods the body with ACTH, it is also flooding it with melanocortin signal — and the MC1R receptors on the skin’s pigment cells read that signal exactly as they would read a tan command, and make dark eumelanin.^[1] The rescue signal aimed at the adrenal is overheard by the skin.

Where it shows, and why that matters

The distribution of the darkening is itself a diagnostic clue, and it is where this differs from a suntan. Addison’s hyperpigmentation favours sun-exposed skin but also, tellingly, places the sun never reaches: the inside of the cheeks and the gums, the creases of the palms, recent scars, and pressure points.^[2] A tan stops at the clothing line; this does not. That pattern tells a clinician the pigment is being driven from within, by a circulating signal, rather than from without by light — melanocortin biology leaving a visible signature.

The same pathway the drugs use

This is the endogenous mirror image of a theme that runs through the therapeutic pages on this site. Melanocortin agonist drugs — setmelanotide, bremelanotide, the melanotan peptides — can all darken skin and gums as a side effect, precisely because they engage MC1R the way excess ACTH does.^[1] Addison’s disease is what happens when the body itself, through sheer physiological necessity, produces that same melanocortin excess. The drugs do deliberately, and locally, what the failing feedback loop does by accident and bodywide. For why skin-darkening comes built into melanocortin agonism, see the trade-off.

The honest bottom line

Addison’s disease is not treated through the melanocortin system — its care is cortisol (and usually aldosterone) replacement, and the adrenal insufficiency itself is serious and can be life-threatening in a crisis. But the disease earns its place here because its signature sign is one of the clearest readouts of melanocortin physiology in all of medicine: restore the cortisol, the pituitary’s brake returns, ACTH falls, and the excess pigment signal fades. For the hormone at the centre of it, see ACTH; for the receptor that reads it in the skin, see MC1R; for the adrenal receptor ACTH is actually aimed at, see MC2R.